NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

IndexS&P 500 P/E34.52 EPS (ttm)2.06 Insider Own0.65% Shs Outstand199.50M Perf Week2.36%
Market Cap14.20B Forward P/E16.10 EPS next Y4.42 Insider Trans0.00% Shs Float198.21M Perf Month-11.01%
Enterprise Value16.67B PEG3.58 EPS next Q1.07 Inst Own101.03% Short Float2.97% Perf Quarter-15.05%
Income414.20M P/S3.56 EPS this Y10.36% Inst Trans1.87% Short Ratio2.39 Perf Half Y-23.33%
Sales3.99B P/B1.71 EPS next Y8.52% ROA3.39% Short Interest5.89M Perf YTD-22.59%
Book/sh41.54 P/C122.18 EPS next 5Y9.64% ROE5.15% 52W High112.38 -36.68% Perf Year-19.10%
Cash/sh0.58 P/FCF38.80 EPS past 3/5Y-49.03% -3.45% ROIC3.83% 52W Low65.00 9.48% Perf 3Y-7.50%
Dividend Est.0.02 (0.02%) EV/EBITDA14.86 Sales past 3/5Y10.05% 7.98% Gross Margin62.18% Volatility2.31% 3.04% Perf 5Y-5.11%
Dividend TTM- EV/Sales4.18 EPS Y/Y TTM21.11% Oper. Margin19.00% ATR (14)2.04 Perf 10Y60.51%
Dividend Ex-DateJul 26, 2023 Quick Ratio1.23 Sales Y/Y TTM6.88% Profit Margin10.39% RSI (14)45.43 Recom1.90
Dividend Gr. 3/5Y- - Current Ratio2.10 EPS Q/Q-1.44% SMA201.57% Beta0.99 Target Price92.87
Payout0.00% Debt/Eq0.31 Sales Q/Q6.33% SMA50-6.91% Rel Volume0.87 Prev Close71.14
Employees16000 LT Debt/Eq0.30 EarningsMay 29 AMC SMA200-21.72% Avg Volume2.46M Price71.16
IPOJan 21, 1983 Option/ShortYes / Yes EPS/Sales Surpr.3.47% 0.70% Trades Volume2,132,480 Change0.03%
Date Action Analyst Rating Change Price Target Change
Jun-17-25Upgrade Needham Hold → Buy $94
May-30-25Downgrade JP Morgan Overweight → Neutral $76
Aug-29-24Reiterated Piper Sandler Overweight $115 → $120
Jul-16-24Upgrade Jefferies Hold → Buy $107 → $115
Mar-19-24Upgrade Redburn Atlantic Neutral → Buy $125
Mar-13-24Upgrade JP Morgan Neutral → Overweight $100 → $120
Feb-06-24Resumed KeyBanc Capital Markets Sector Weight
Oct-30-23Initiated BofA Securities Buy $380
Oct-05-23Downgrade Redburn Atlantic Overweight → Neutral $390 → $343
May-30-23Initiated Morgan Stanley Equal-Weight $410
Jun-23-25 11:31PM
09:32AM
Jun-19-25 11:20AM
Jun-18-25 09:51AM
Jun-07-25 09:47AM
05:37PM Loading…
Jun-05-25 05:37PM
Jun-03-25 09:45AM
Jun-02-25 09:40AM
09:15AM
08:43AM
May-30-25 08:47PM
02:13PM
12:41PM
11:59AM
11:40AM
09:32AM Loading…
09:32AM
03:08AM
May-29-25 09:10PM
06:00PM
05:30PM
04:51PM
04:30PM
04:15PM
09:29AM
May-28-25 03:03AM
May-23-25 09:15AM
May-22-25 09:18AM
May-20-25 04:15PM
07:48AM
May-15-25 06:35PM
11:40AM Loading…
May-14-25 11:40AM
07:47AM
May-12-25 07:33PM
May-08-25 04:15PM
07:10AM
12:36AM
May-07-25 05:45PM
May-06-25 09:45AM
May-01-25 07:55AM
Apr-30-25 04:15PM
Apr-29-25 04:15PM
Apr-21-25 10:40AM
Apr-17-25 11:17AM
Apr-03-25 07:36PM
05:04AM
Mar-24-25 07:30PM
Mar-17-25 03:12PM
Mar-13-25 07:24PM
05:04AM
Mar-08-25 03:39PM
Mar-07-25 04:35PM
12:13PM
02:17AM
Mar-06-25 07:21PM
06:00PM
05:25PM
04:26PM
04:25PM
04:15PM
Mar-05-25 08:03AM
Mar-03-25 09:15AM
Feb-21-25 08:01AM
Feb-03-25 04:15PM
Jan-08-25 08:46AM
Dec-17-24 04:15PM
Dec-13-24 07:36PM
Dec-09-24 09:15AM
Dec-06-24 09:47AM
08:16AM
02:03AM
Dec-05-24 07:00PM
05:25PM
04:34PM
04:15PM
Dec-02-24 01:29PM
Nov-28-24 12:22PM
Nov-12-24 04:15PM
Oct-30-24 08:10AM
Sep-19-24 12:00PM
Sep-12-24 09:55AM
Sep-10-24 04:28PM
Sep-03-24 04:15PM
Sep-02-24 09:15AM
Aug-30-24 01:24AM
Aug-29-24 06:35PM
11:06AM
10:52AM
Aug-28-24 06:00PM
05:25PM
04:26PM
04:15PM
Aug-27-24 09:02AM
Aug-26-24 12:10PM
08:28AM
Aug-23-24 12:00PM
09:15AM
Aug-08-24 04:15PM
Aug-06-24 04:15PM
Aug-01-24 04:15PM
Jul-24-24 08:04AM
The Cooper Cos, Inc. operates as a medical device company. It operates through the Cooper Vision and Cooper Surgical segments. The Cooper Vision segment develops, manufactures, and markets products for contact lens wearers, which solves vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues. The Cooper Surgical segment focuses on the provision of advancement for the health of women, babies, and families through women's health and fertility products and services. The company was founded in 1958 and is headquartered in San Ramon, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KOZY WILLIAM ADirectorApr 01 '25Option Exercise0.002,857031,149Apr 03 04:09 PM
WEISS ROBERT SDirectorApr 01 '25Option Exercise0.002,9930288,945Apr 03 04:09 PM
Rivas MariaDirectorApr 01 '25Option Exercise0.002,72102,721Apr 03 04:08 PM
MADDEN TERESA SDirectorApr 01 '25Option Exercise0.002,721012,357Apr 03 04:08 PM
Lucchese Cynthia LDirectorApr 01 '25Option Exercise0.002,72107,661Apr 03 04:07 PM
Kurzius Lawrence ErikDirectorApr 01 '25Option Exercise0.002,72103,777Apr 03 04:07 PM
Jay ColleenDirectorApr 01 '25Option Exercise0.002,721029,521Apr 03 04:06 PM
Ricupati AgostinoSVP & CAOApr 01 '25Option Exercise0.002,07609,044Apr 03 04:06 PM
McBride Daniel GEVP & Chief Operating OfficerFeb 01 '25Option Exercise0.0022,777071,687Feb 04 04:25 PM
White Albert G IIIPresident & CEOFeb 01 '25Option Exercise0.0084,2640258,941Feb 04 04:25 PM
Andrews Brian GEVP, CFO & TreasurerFeb 01 '25Option Exercise0.0016,850023,464Feb 04 04:24 PM
Sheffield Holly RPresident, CSIFeb 01 '25Option Exercise0.0017,309045,843Feb 04 04:24 PM
White Albert G IIIPresident & CEOJan 08 '25Option Exercise0.0018,3400183,613Jan 10 04:12 PM
Warner Gerard H IIIPresident, CooperVision, Inc.Jan 08 '25Option Exercise0.0013,328023,763Jan 10 04:12 PM
Sheffield Holly RPresident, CSIJan 08 '25Option Exercise0.004,900030,898Jan 10 04:11 PM
Ricupati AgostinoSVP & CAOJan 08 '25Option Exercise0.004,47209,328Jan 10 04:11 PM
McBride Daniel GEVP & Chief Operating OfficerJan 08 '25Option Exercise0.008,728053,424Jan 10 04:11 PM
Andrews Brian GEVP, CFO & TreasurerJan 08 '25Option Exercise0.006,420013,034Jan 10 04:10 PM
Khadder NicholasVP, General Counsel & Corp SecJan 08 '25Option Exercise0.003,49204,369Jan 10 04:10 PM
White Albert G IIIPresident & CEOSep 19 '24Option Exercise43.83114,9925,040,099280,265Sep 20 05:51 PM
White Albert G IIIPresident & CEOSep 19 '24Sale110.53114,99212,710,041165,273Sep 20 05:51 PM
Albert G. White IIIOfficerSep 19 '24Proposed Sale110.53114,99212,709,660Sep 19 03:53 PM
Ricupati AgostinoSVP & CAOSep 10 '24Sale108.031,601172,9554,818Sep 11 05:50 PM
Agostino RicupatiDirectorSep 10 '24Proposed Sale108.031,601172,950Sep 10 01:47 PM
Andrews Brian GEVP, CFO & TreasurerSep 05 '24Option Exercise37.9124,788939,73431,402Sep 06 04:58 PM
Andrews Brian GEVP, CFO & TreasurerSep 05 '24Sale105.9024,7882,625,0726,614Sep 06 04:58 PM
McBride Daniel GEVP & Chief Operating OfficerSep 04 '24Option Exercise43.83114,9925,040,099159,688Sep 06 04:56 PM
McBride Daniel GEVP & Chief Operating OfficerSep 04 '24Sale105.48114,99212,129,91144,696Sep 06 04:56 PM
Brian G. AndrewsOfficerSep 05 '24Proposed Sale105.9024,7882,624,952Sep 05 01:22 PM
Daniel McBrideOfficerSep 04 '24Proposed Sale105.48114,99212,129,545Sep 04 04:18 PM
Last Close
Jun 30 04:00PM ET
29.40
Dollar change
+0.02
Percentage change
0.07
%
OMCL Omnicell, Inc daily Stock Chart
IndexRUT P/E64.70 EPS (ttm)0.45 Insider Own3.33% Shs Outstand46.84M Perf Week3.63%
Market Cap1.38B Forward P/E19.24 EPS next Y1.53 Insider Trans0.68% Shs Float45.28M Perf Month-1.44%
Enterprise Value1.35B PEG- EPS next Q0.27 Inst Own101.31% Short Float5.42% Perf Quarter-16.02%
Income21.18M P/S1.21 EPS this Y-24.26% Inst Trans-1.50% Short Ratio3.71 Perf Half Y-31.94%
Sales1.14B P/B1.10 EPS next Y17.98% ROA0.96% Short Interest2.46M Perf YTD-33.96%
Book/sh26.84 P/C3.32 EPS next 5Y-2.76% ROE1.73% 52W High55.74 -47.26% Perf Year12.13%
Cash/sh8.85 P/FCF11.02 EPS past 3/5Y-44.95% -28.29% ROIC1.45% 52W Low22.66 29.74% Perf 3Y-75.00%
Dividend Est.- EV/EBITDA13.36 Sales past 3/5Y-0.59% 4.39% Gross Margin43.24% Volatility2.70% 2.67% Perf 5Y-58.54%
Dividend TTM- EV/Sales1.19 EPS Y/Y TTM199.91% Oper. Margin1.11% ATR (14)0.92 Perf 10Y-24.11%
Dividend Ex-Date- Quick Ratio1.21 Sales Y/Y TTM3.00% Profit Margin1.87% RSI (14)50.03 Recom1.89
Dividend Gr. 3/5Y- - Current Ratio1.36 EPS Q/Q56.04% SMA20-1.13% Beta0.77 Target Price42.29
Payout0.00% Debt/Eq0.31 Sales Q/Q9.55% SMA500.28% Rel Volume0.59 Prev Close29.38
Employees3670 LT Debt/Eq0.16 EarningsMay 06 BMO SMA200-23.79% Avg Volume662.71K Price29.40
IPOAug 07, 2001 Option/ShortYes / Yes EPS/Sales Surpr.27.08% 3.74% Trades Volume391,519 Change0.07%
Date Action Analyst Rating Change Price Target Change
May-14-25Upgrade Wells Fargo Equal Weight → Overweight $35
Oct-31-24Downgrade BofA Securities Buy → Neutral $44 → $57
Aug-02-24Upgrade Barclays Underweight → Equal Weight $26 → $39
Jan-03-24Initiated Barclays Underweight $33
Nov-03-23Upgrade Wells Fargo Underweight → Equal Weight $39 → $28
Nov-03-23Upgrade Piper Sandler Neutral → Overweight $70 → $39
Nov-03-23Downgrade BTIG Research Buy → Neutral
Oct-11-23Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Sep-26-23Reiterated Wells Fargo Underweight $56 → $39
Aug-02-23Downgrade Piper Sandler Overweight → Neutral $66 → $70
Jun-26-25 05:58PM
Jun-16-25 11:38PM
Jun-13-25 08:42AM
Jun-06-25 09:02AM
Jun-05-25 11:31AM
05:59AM Loading…
May-31-25 05:59AM
May-22-25 01:25PM
08:30AM
May-19-25 08:33AM
May-15-25 08:55AM
May-14-25 04:01PM
08:30AM
May-07-25 01:25PM
09:20AM
03:07AM
01:35AM Loading…
01:35AM
May-06-25 07:40AM
06:43AM
06:30AM
May-02-25 10:56AM
Apr-29-25 05:06AM
Apr-28-25 09:40AM
05:04AM
Apr-27-25 01:09PM
Apr-22-25 07:29AM
Apr-14-25 04:01PM
Apr-10-25 05:08PM
09:40AM
Apr-08-25 05:12AM
Mar-25-25 09:40AM
04:01PM Loading…
Mar-24-25 04:01PM
Mar-12-25 08:30AM
Feb-28-25 08:02AM
Feb-24-25 12:00PM
Feb-11-25 09:55AM
Feb-07-25 02:11AM
Feb-06-25 07:45AM
07:06AM
06:55AM
06:30AM
Feb-05-25 08:11AM
Jan-13-25 05:47PM
Jan-08-25 04:01PM
Dec-18-24 12:20PM
Dec-12-24 12:00PM
Dec-09-24 08:30AM
Nov-29-24 11:31AM
Nov-22-24 04:01PM
Nov-21-24 09:55AM
Nov-20-24 02:00AM
Nov-18-24 04:12PM
Nov-06-24 12:20PM
Oct-31-24 09:15AM
07:00AM
Oct-30-24 04:25PM
07:45AM
06:41AM
06:30AM
Oct-11-24 12:14PM
Oct-07-24 05:35PM
Oct-04-24 12:00PM
Sep-25-24 04:01PM
Aug-28-24 12:20PM
Aug-21-24 09:04AM
Aug-20-24 04:30PM
Aug-15-24 04:01PM
Aug-02-24 09:23AM
Aug-01-24 09:00AM
07:45AM
06:43AM
06:30AM
Jul-25-24 10:02AM
Jul-24-24 07:50AM
Jul-15-24 04:01PM
Jul-03-24 11:39AM
Jun-10-24 08:33AM
Jun-03-24 11:37AM
May-06-24 04:23PM
08:02AM
May-03-24 04:01PM
12:13PM
03:11AM
May-02-24 10:44PM
01:34PM
12:54PM
08:56AM
08:45AM
07:44AM
07:30AM
Apr-22-24 04:05PM
Apr-16-24 04:01PM
Apr-08-24 04:01PM
Mar-27-24 07:49AM
07:38AM
Mar-19-24 04:27PM
Mar-11-24 05:11PM
Mar-01-24 08:43AM
Feb-23-24 05:15AM
Feb-12-24 07:43AM
Feb-09-24 10:21AM
Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. Its solutions include intelligence, platform and interoperability, central pharmacy dispensing, medication adherence, population health and point of care automation. The company was founded by Randall A. Lipps in September 1992 and is headquartered in Fort Worth, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LIPPS RANDALL ACHAIRMAN, PRESIDENT AND CEOMar 14 '25Buy33.1310,561349,874333,610Mar 18 04:13 PM
PARRISH MARK WDirectorDec 10 '24Sale47.3012,000567,63858,427Dec 12 04:03 PM
PARRISH MARK WDirectorDec 10 '24Proposed Sale46.0012,000552,000Dec 10 04:51 PM